In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2007-04-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00452-07PMID 17452481PMCID PMC1913247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard

  2008cited by this paper
• Posaconazole as Salvage Therapy for Zygomycosis

  2006cited by this paper
• Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

  2006influential reference
• In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts

  2006cited by this paper
• Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.

  2006cited by this paper
• Zygomycosis in Solid Organ Transplant Recipients in a Tertiary Transplant Center and Review of the Literature

  2006influential reference
• Erratum: Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases (Clinical Infectious Diseases (April 1, 2006) 42 (e61-e65))

  2006cited by this paper
• Comparison of Three Commercial Assays and a Modified Disk Diffusion Assay with Two Broth Microdilution Reference Assays for Testing Zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with Posaconazole and Amphotericin B

  2006cited by this paper
• Combination Therapy with Amphotericin B Lipid Complex and Caspofungin Acetate of Disseminated Zygomycosis in Diabetic Ketoacidotic Mice

  2005cited by this paper
• Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

  2005cited by this paper
• Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

  2005cited by this paper
• In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38‐A microdilution method

  2005cited by this paper
• Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis

  2004cited by this paper
• Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

  2003cited by this paper
• In vitro susceptibilities of zygomycetes to conventional and new antifungals.

  2003cited by this paper
• Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis

  2003cited by this paper
• In Vivo Activity of Posaconazole against Mucor spp. in an Immunosuppressed-Mouse Model

  2002cited by this paper
• Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis

  2002influential reference
• Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans

  2002influential reference
• Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000

  2002cited by this paper
• In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes

  2002cited by this paper
• In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus andFusarium Isolates

  2001cited by this paper
• Zygomycetes in human disease.

  2000cited by this paper
• Zygomycosis in the 1990s in a tertiary-care cancer center.

  2000influential reference
• In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.

  1998cited by this paper
• In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens

  1994cited by this paper
• Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

  1994cited by this paper
• Mucormycosis.

  1992cited by this paper
• Agents of mucormycosis and related species.

  1990cited by this paper
• Mucormycosis.

  1986cited by this paper
• Principles and practice of infectious diseases. Vols 1 and 2.

  1979cited by this paper

• Diagnostic Challenges in Fungal Coinfections Associated With Global COVID-19

  2025cites this paper
• Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus

  2025cites this paper
• Sinusites fongiques

  2025cites this paper
• Antifungal Minimal Inhibitory Concentrations of Mold Isolates from Patients with Cancer; Single-Center Experience, 2018–2023

  2025cites this paper
• Invasive fungal infections and oomycoses in cats 2. Antifungal therapy

  2024cites this paper
• Trans-kingdom fungal pathogens infecting both plants and humans, and the problem of azole fungicide resistance

  2024cites this paper
• Thamnostylum piriforme, a novel etiological agent of superficial mycosis.

  2024cites this paper
• A Comprehensive Analysis of the Lipidomic Signatures in Rhizopus delemar

  2024cites this paper
• Syncephalastrum massiliense sp. nov. and Syncephalastrum timoneanum sp. nov. Isolated from Clinical Samples

  2024cites this paper
• Exposure to resistant fungi across working environments and time.

  2024cites this paper
• An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales.

  2024cites this paper
• Molecular mechanisms that govern infection and antifungal resistance in Mucorales

  2024cites this paper
• Fatal hepatic mucormycosis in an allogeneic hematopoietic-stem cell transplanted patient: Case report of a rare presentation and review of the literature.

  2024cites this paper
• Rhino-Orbital Cerebral Mucormycosis: A Fatal Evolution

  2023cites this paper
• Mucormycosis in 2023: an update on pathogenesis and management

  2023cites this paper
• Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex

  2023cites this paper
• Disseminated Mucor indicus infection in a marmoset (Callithrix sp.)

  2023cites this paper
• A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM)

  2023cites this paper
• Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections

  2023cites this paper
• Rise of mucormycosis during the COVID-19 pandemic and the challenges faced

  2023cites this paper
• Biological features of fungi of the genus Mucor

  2023cites this paper
• In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens

  2023cites this paper
• What Is New in Pulmonary Mucormycosis?

  2023cites this paper
• The SSS revolution in fungal diagnostics: speed, simplicity and sensitivity

  2023cites this paper
• A pediatric case and literature review of mucormycosis: Diagnostic and treatment challenges in a resource poor setting

  2023cites this paper
• Rapid detection of Mucorales based on recombinase polymerase amplification and real-time PCR

  2023cites this paper
• Effect of antifungal drugs against mucormycosis and impact on human health

  2023cites this paper
• Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now

  2023cites this paper
• Uncommon pathogens in an immunocompetent host: respiratory isolation of Cunninghamella bertholletiae, Aspergillus niger, Staphylococcus pseudintermedius and adenovirus in a patient with necrotising pneumonia

  2022cites this paper
• Zygomycosis in Children: Disseminated Infection Caused by Cunninghamella bertholletiae

  2022cites this paper
• Utility of itraconazole and terbinafine in mucormycosis: a proof-of-concept analysis

  2022cites this paper
• Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases

  2022cites this paper
• Fatal disseminated mucormycosis due to Cunninghamella bertholletiae infection after ABO-incompatible living donor liver transplantation: a case report

  2022cites this paper
• Zygomycosis in Children: Disseminated Infection Caused by Cunninghamella bertholletiae

  2022cites this paper
• Mucormycosis in the COVID-19 Environment: A Multifaceted Complication

  2022cites this paper
• Mucromycosis in India: Pathophysiology and Perspectives on Treatment and Management.

  2022cites this paper
• Black Fungi in Arabian Horses: Scanning Electron Microscopy Study of Cutaneous Equine Mucormycosis Caused by Mucor indicus for the First Time in Eastern Province, Saudi Arabia

  2022cites this paper
• Mucormycosis

  2022cites this paper
• COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic

  2022cites this paper
• Review on Mucormycosis the uprising infection and post COVID effect

  2022cites this paper
• A rare post-coronavirus disease 2019 complication of maxillary mucormycotic osteomyelitis in a Southeast Asian patient

  2022cites this paper
• Mucormycosis: The hidden and forgotten disease

  2022cites this paper
• Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes

  2021cites this paper
• Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study

  2021cites this paper
• Characterization of Three Pleiotropic Drug Resistance Transporter Genes and Their Participation in the Azole Resistance of Mucor circinelloides

  2021cites this paper
• MUCORMYCOSIS: A SYSTEMATIC REVIEW

  2021cites this paper
• “Mucormycosis” The Emerging Global Threat – A Complete Review

  2021cites this paper
• Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient

  2021cites this paper
• Echinocandins

  2021cites this paper
• A Review on Mucormycosis with recent pharmacological treatment

  2021cites this paper
• Susceptibility of Filamentous Fungi to Voriconazole in Malaysia Tested by Sensititre YeastOne and CLSI Microdilution Methods

  2021cites this paper
• Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis

  2021cites this paper
• New insights on mucormycosis and its association with the COVID-19 pandemic

  2021cites this paper
• A Case Series of Pulmonary Mucormycosis Caused by Rhizopus Microsporus

  2021cites this paper
• Iron Assimilation during Emerging Infections Caused by Opportunistic Fungi with emphasis on Mucorales and the Development of Antifungal Resistance

  2020cites this paper
• Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance

  2020cites this paper
• Gastric Mucormycosis: An Infection of Fungal Invasion into the Gastric Mucosa in Immunocompromised Patients

  2020cites this paper
• Zygomycosis in Children: Disseminated Infection Caused by Cunninghamella bertholletiae

  2020cites this paper
• Mucormicosis «rinoorbitaria» en niños con inmunosupresión. Serie de tres casos y revisión de la literatura

  2020cites this paper
• In Vitro Evaluation of Radiolabeled Amphotericin B for Molecular Imaging of Mold Infections

  2020cites this paper
• α- and β-1,3-Glucan Synthesis and Remodeling.

  2020cites this paper
• First reported case of Gilbertella persicaria in human stool: outcome of a community study from Segamat, Johor, Malaysia

  2020cites this paper
• Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of 1 pulmonary mucormycosis 2

  2020cites this paper
• Mucormycosis

  2020cites this paper
• Fundamentals of Mycology for Infection Control and Prevention

  2020cites this paper
• Zygomycosis in Children: Disseminated Infection Caused by Cunninghamella bertholletiae

  2020cites this paper
• Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis.

  2020cites this paper
• Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

  2019cites this paper
• Phenolic composition, antioxidant and anticholinesterase properties of the three mushrooms Agaricus silvaticus Schaeff., Hydnum rufescens Pers. and Meripilus giganteus (Pers.) Karst. in Tunisia

  2019cites this paper
• Mucormycosis

  2019cites this paper
• Mucormycosis

  2019cites this paper
• A Revised Species Concept for Opportunistic Mucor Species Reveals Species-Specific Antifungal Susceptibility Profiles

  2019cites this paper
• Role of Arf-like proteins (Arl1 and Arl2) of Mucor circinelloides in virulence and antifungal susceptibility.

  2019cites this paper
• Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections

  2019cites this paper
• Treatment of Non-Aspergillus Mold Infections: a Focus on Mucormycosis and Fusariosis

  2019cites this paper
• Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.

  2019cites this paper
• Antifungal combinations in Mucorales: A microbiological perspective

  2019cites this paper
• Management of Infections in the Immunocompromised Host

  2018cites this paper
• Invasive fungal sinusitis in immunocompromised hosts

  2018cites this paper
• Components of a new gene family of ferroxidases involved in virulence are functionally specialized in fungal dimorphism

  2018cites this paper
• Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment

  2018cites this paper
• Antifungal-resistant Mucorales in different indoor environments

  2018cites this paper
• Infections in Hematopoietic Stem Cell Transplant Recipients

  2018cites this paper
• Advanced Molecular Diagnosis of Fungal Infections

  2018cites this paper
• Challenges in the diagnosis and treatment of mucormycosis.

  2018cites this paper
• Recent advances in the understanding and management of mucormycosis

  2018cites this paper
• Invasive cutaneous mucormycosis in an extremely preterm infant

  2018cites this paper
• Necrotizing fasciitis caused by Mucor indicus in a pediatric bone marrow transplant recipient

  2018cites this paper
• Components of a new gene family of ferroxidases involved in virulence are functionally specialized in fungal dimorphism

  2018cites this paper
• Osteomyelitis of left Maxillary Region due to Mucor Infection

  2017cites this paper
• Rare fungal infectious agents: a lurking enemy

  2017cites this paper
• [Fungal sinusitis].

  2017cites this paper
• 156 – Systemic Antifungal Agents

  2017cites this paper
• Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase

  2017cites this paper
• Future Research Priorities in Fungal Resistance

  2017cites this paper
• Disseminated mucormycosis: (almost) fatal!

  2017cites this paper
• The Role of Transbronchial Lung Biopsy in Diagnosing Pulmonary Mucormycosis in a Critical Care Unit

  2017cites this paper
• Mucormicosis pulmonar en niños. Presentación de 3 casos y revisión de la literatura

  2017cites this paper
• Antifungal resistance in mucorales.

  2017cites this paper
• Real-Life Challenges to the Use of Antifungal Agents in Hematology Patients

  2017cites this paper